
Editorial Picks
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis

The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis

PRESS RELEASE TILRAY Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and

IN June last year the Irish Government signed-off on its five-year medicinal cannabis programme – but no patients have yet